These findings highlight the therapeutic potential of targeting cyclic nucleotide signaling to enhance tyrosine hydroxylase activity, which could offer a novel treatment strategy for the motor symptom control in Parkinson’s disease. The gene discussed is TH; the disease is Parkinson disease.